- Home
- RDCM vs ACHV Comparison
RDCM vs ACHV Comparison
Compare RDCM & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDCM
- ACHV
- Stock Information
- Founded
- RDCM 1985
- ACHV N/A
- Country
- RDCM Israel
- ACHV Canada
- Employees
- RDCM N/A
- ACHV N/A
- Industry
- RDCM Computer peripheral equipment
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RDCM Technology
- ACHV Health Care
- Exchange
- RDCM Nasdaq
- ACHV Nasdaq
- Market Cap
- RDCM 157.9M
- ACHV 159.0M
- IPO Year
- RDCM 1997
- ACHV N/A
- Fundamental
- Price
- RDCM $11.61
- ACHV $4.25
- Analyst Decision
- RDCM Strong Buy
- ACHV Strong Buy
- Analyst Count
- RDCM 1
- ACHV 5
- Target Price
- RDCM $14.00
- ACHV $14.80
- AVG Volume (30 Days)
- RDCM 68.6K
- ACHV 112.1K
- Earning Date
- RDCM 11-13-2024
- ACHV 11-07-2024
- Dividend Yield
- RDCM N/A
- ACHV N/A
- EPS Growth
- RDCM 660.55
- ACHV N/A
- EPS
- RDCM 0.46
- ACHV N/A
- Revenue
- RDCM $58,755,000.00
- ACHV N/A
- Revenue This Year
- RDCM $17.18
- ACHV N/A
- Revenue Next Year
- RDCM $11.32
- ACHV N/A
- P/E Ratio
- RDCM $25.00
- ACHV N/A
- Revenue Growth
- RDCM 17.80
- ACHV N/A
- 52 Week Low
- RDCM $7.63
- ACHV $3.03
- 52 Week High
- RDCM $12.44
- ACHV $5.98
- Technical
- Relative Strength Index (RSI)
- RDCM 61.09
- ACHV 35.58
- Support Level
- RDCM $10.21
- ACHV $4.32
- Resistance Level
- RDCM $12.44
- ACHV $4.75
- Average True Range (ATR)
- RDCM 0.54
- ACHV 0.23
- MACD
- RDCM 0.10
- ACHV -0.06
- Stochastic Oscillator
- RDCM 68.44
- ACHV 9.40
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.